Hims(HIMS) ZACKS·2024-11-04 23:46Earnings Performance - Hims & Hers Health reported quarterly earnings of 0.04 per share a year ago [1] - The company delivered a 20% earnings surprise in the previous quarter, surpassing the expected 0.06 per share [1] - Over the last four quarters, the company has exceeded consensus EPS estimates three times [1] Revenue Growth - Hims & Hers Health posted revenues of 226.7 million [2] - The company has topped consensus revenue estimates four times over the last four quarters [2] Stock Performance - Hims & Hers Health shares have surged approximately 128.8% since the beginning of the year, outperforming the S&P 500's gain of 20.1% [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] Earnings Outlook - The current consensus EPS estimate for the coming quarter is 424.7 million in revenues [7] - For the current fiscal year, the consensus EPS estimate is 1.4 billion in revenues [7] - The estimate revisions trend for Hims & Hers Health is mixed, resulting in a Zacks Rank 3 (Hold) [6] Industry Context - Hims & Hers Health operates in the Zacks Medical Info Systems industry, which is currently in the top 30% of the 250 plus Zacks industries [8] - The top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [8] Peer Comparison - Clover Health Investments, Corp. (CLOV) is expected to report a quarterly loss of 347.6 million, down 27.9% from the year-ago quarter [10] - The consensus EPS estimate for Clover Health has remained unchanged over the last 30 days [9]